Aiming at the characteristics of hematological tumor diseases

the ancient clinical efficacy evaluation methods of traditional Chinese medicine was briefly introduced.Combined with modern Chinese medicine hematological tumor clinical efficacy evaluation indicators

from the aspects of clinical research design

blind design and the weight of TCM observation indicators

the clinical efficacy evaluation method for hematological tumor diseases was explored.It was emphasized that blood tumors were refractory diseases.In order to reflect the overall therapeutic effect

it is necessary to change from a single evaluation index to diversified index integration.In terms of blind design

such as the international standard of blood tumor efficacy indicators

in a strictly random

controlled case

blind method cannot be used;For clinical researches with clinical syndrome

symptoms

quality of life as the main observational indicators

the blind method must be used to design and establish a scientific evaluation method and evaluation system.For the treatment of non-responsive or relapsed and refractory hematological tumors

it should adhere to the concept of"people-oriented

treatment-for-living

"and""survival with tumors"to increase the weight of clinical syndrome（symptoms）improvement

quality of life

and prolonged survival

which can make the patient benefit clinically.